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Summary
Recent studies indicate that there may be functional uncoupling of the TCR-CD3 complex
and suggest that the TCR-CD3 complex is composed of two parallel signal-transducing units,
one made ofy8E chains and the other of ~ chains. To elucidate the molecular mechanism that
may explain the functional uncoupling of TCR and CD3, we have analyzed their expression
by using flow cytometry as well as immunochemical means both before and after stimulation
with anti-TCR-R, anti-CD3E, anti-CD2, staphylococcal enterotoxin B, and ionomycin. We
present evidence that TCR physically dissociates from CD3 after stimulation of the TCR-
CD3 complex. Stimulation with anti-CD3 resulted in down-modulation of TCR within 45
min whereas CD3E was still expressed on the cell surface as detected by flow cytometry. How-
ever, the cell surface expression of TCR and CD3 was not affected when cells were stimulated
with anti-TCR-R under the same conditions. In the case of anti-CD3 treatment of T cells, the
TCR down-modulation appeared to be due to the internalization of TCR, as determined by
immunoelectron microscopy. Immunochemical analysis of cells after stimulation with either
anti-TCR or anti-CD3 mAbs revealed that the overall protein levels of TCR and CD3 were
similar. More interestingly, the dissociation of the TCR-CD3 complex was observed with
both treatments and occurred in a manner that the TCR and the associated TCR-~ chain dis-
sociated as a unit from CD3. These results provide the first report of physical dissociation of
TCR and CD3 after stimulation through the TCR-CD3 complex. The results also suggest
that the signal transduction pathway triggered by TCR may differ from that induced by CD3 .
T lymphocytes, which play an important role in im-
mune responses, recognize antigens on the surface of
APCs in the context of molecules encoded by the MHC by
virtue of the heterodimeric TCR. For TCR-a/(3 T cells,
the antigen recognition unit is composed ofpolymorphic a
and (3 subunits and is expressed at the cell surface as a mo-
lecular complex with CD3 and members of the TCR-4
chain family (1-4). The CD3 subunits y, 8, and E and the
TCR-t chain are invariant and thought to be responsible
for signal transduction after ligation of the TCR by antigen
(5, 6). Recent studies have shown that the CD3 subunits in
the antigen recognition ensemble are expressed as nonco-
valently associated yE and 8E pairs (2-4) . The TCR-~ fam-
ily includes the 4 and 9 chains and the y chain ofthe high-
affinity IgE receptor (FCERI) and is expressed not only in T
cells but also in other cell types (6-8) . These C, 9, and
FCERIy subunits can exist as homodimers or can combine
to form heterodimers (9). Thus, the minimal TCR complex
is made up of at least eight polypeptide chains.
Biosynthetic labeling studies in mature T, cells have dem-
onstrated that TCR-ot/R, CD3y, CD38, and CD3E chains
are indispensable for expression of the antigen receptor
complex on the cell surface (10, 11) . Although TCR-CD3
complexes can be expressed on the cell surface without ~-~
or ~-q subunits, surface expression is <10% of the full oc-
tameric TCR complex (ot, (3, 8, y, E2, and 1 ;2) . Because
TCR-4 chain association with the TCR-CD3 complex is
essential for signal transduction, the complete octameric
TCR complex is thought to be required for optimal ex-
pression on the cell surface and receptor function.
Reports suggest the occurrence of functional uncoupling
between TCR and CD3 (12-16), but no study has ad-
dressed the fate of the complex when ligation ofthe TCR
takes place. During maturation of immature thymocytes,
treatment with anti-CD3 mAb resulted in the elimination
of all CD4+8+ thymocytes, whereas anti-TCR mAb treat-
ment caused the deletion of only one-half of immature
thymocytes. The cells that remained after anti-TCR mAb
treatment failed to mobilize Cal+ upon stimulation with
anti-TCR but mobilized Ca
ll
with anti-CD3, suggesting
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￿
J. Exp. Med. C The Rockefeller UniversityPress " 0022-1007/95/12/1997/10 $2.00
Volume 182 December 1995 1997-2006that uncoupling occurred between TCR and CD3 in these
cells (12, 13). In peripheral (mature) T cells, signal trans-
duction through CD4 with p56ick inhibits the proliferation
induced by the ligation ofTCR-a/(3 but is unable to affect
the induction of growth through the CD3 complex (15) .
These results led us to suspect that TCR-ot/(3 could physi-
ologically dissociate from CD3 upon ligation of the recep-
tor complex. In this study, we demonstrate this uncoupling
through analysis ofthe expression ofTCR and CD3 before
and after stimulation with anti-TCR-(3, anti-CD3e, and
anti-CD2 mAbs, staphylococcal enterotoxin B (SEB)', and
ionomycin. Using flow cytometric analysis, we found that
stimulation with anti-CD3 mAb resulted in the down-
modulation of the TCR, although CD3 surface expression
was at normal levels, whereas the cell surface expression of
TCR and CD3 was not affected when cells were stimu-
lated with the anti-TCR-(3 mAb. The fate of the TCR
complex after stimulation o£ T cells with either anti-TCR
or -CD3 was also analyzed by immunoelectron microscopy
and by immunoprecipitation and immunoblot analysis. We
demonstrate here that dissociation of the TCR from CD3
can occur after stimulation via the TCR-CD3 complex
and suggest that the signal transduction pathway triggered
by TCR may differ from that induced by CD3 ligation .
Materials and Methods
Animals, Cells and Antibodies.
￿
C3H/HeN (C3H) andC57BL/6
(B6) mice were produced in our animal facility (Research Insti-
tute forBiological Sciences, Science University of Tokyo, Chiba,
Japan). Anti-H-Y TCR VR8 transgenic mice were established by
Drs. H. von Boehmer and M. Steinmetz (17) andwere provided
by Dr. Alfred Singer (National Cancer Institute, Bethesda, MD).
LK35.2, a B cell hybridoma (FcR+ andMHC class II+), was used
as a cross-linker of mAbs or the APC for superantigen during the
stimulation of T cell clones (18). T cell clones MS-S2 (I-Ak au-
toreactive) and24-2 (specific for I-Ab plus KLH) were established
in our laboratory (Department of Immunology, Faculty of Medi-
cine, University of Tokyo, Tokyo, Japan) (19, 20).
The mAbs used for stimulation and staining of TCR were
H57-597 (anti-TCR-R) (21), F23.1 (anti-TCR V(38) (22), 145-
2C11 (anti-CD3e) (23), 500.A2 (anti-CD3e) (24), and RM-2.1
(anti-CD2) (25). HMT3-1 (anti-CD3e) (26), H28-710 (anti-
TCR-a.) (27), H146-968A (anti-TCR-C) (28), and 4G10 (an-
tiphosphotyrosine; Upstate Biotechnology, Inc., Lake Placid,
NY) were used for immunoprecipitationandimmunoblotting anal-
ysis. Rat mAb against mouse Thyl (30H-12) (Becton Dickinson
& Co., Mountain View, CA) was used for two-colorstaining.
Cell Stimulation and Flow Cytometry (FCM) Analysis.
￿
Freshly
isolated spleen cellswere incubatedwith 10 N.g/ml ofanti-TCR-(3
(H57-597), 10 Kg/ml ofanti-CD3e (145-2C11, 500.A2), 10 p,g/
ml ofanti-V(38 (F23.1), 10 l.tg/ml ofanti-CD2 (RM-2.1), 10 RM
ofionomycin (Sigma Chemical Co., St. Louis, MO), or 10 Kg/ml
of SEB (Sigma Chemical Co.) . For stimulation of T cell clones,
cells were incubated with mAbs against the TCR-CD3 complex
in the presence ofB cell hybridoma, LK35.2. Stimulation of cells
was stopped by the addition of ice-cold PBS containing kinase
'Abbreviations used in this paper: DN, double negative; FCM, flow cytom-
etry; SEB, staphylococcal enterotoxin B.
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and phosphatase inhibitors (1 mM sodium orthovanadate, 1 mM
EDTA, 10 N.g/ml leupeptin, 10 N,g/ml aprotinin, and 25 mM
p-nitrophenylp-guanidinobenzoate) . Afterstimulation, cellswere
incubated with anti-TCR-(3 or anti-CD3e mAbs, followed by
FITC-conjugated goat anti-hamster Ig for indirect staining.
When the stimulating antibody andthe staining antibody were the
same, indirect staining method was used. For direct staining, cells
were stainedwith FITC-conjugated anti-TCR-(3 (H57-597-FITC)
or anti-CD3e (145-2C11-FITC). Anti-Thyl-biotin (30H-12-bio-
tin) followed by streptavidin PE was used for spleen cells analyzed
by two-color FCM analysis to track Thyl+ cells. FCM analysis was
performed on the FACStar® Plus (Becton Dickinson & Co.).
Immunoprecipitation and Immunoblotting Analysis. Cells were
harvested, washed in PBS, and lysed in 1% digitonin or 1% NP-
40, 10 mM Tris, pH 7.5, and 150 mM NaCl with the phos-
phatase inhibitors indicated above. Postnuclear supernatants of
digitonin lysates from 3 X 107 cells were subjected to immuno-
precipitation for 1 h with hamster mAbs, as described previously
(20) . The immune complexes were washed in PBS containing
0.5% digitonin and the phosphatase inhibitors indicated above,
solubilized in SDS sample buffer containing 5% 2-ME, and sepa-
rated by SDS-PAGE, as described by Laemmli (29) and trans-
ferred to polyvinylidene difluoride membranes. Membranes were
blocked with 5% BSA (or 5% skim milk) in PBS andwere incu-
bated with the appropriate primary antibody followed by
125iodine-labeled protein A. The amount of protein detected was
estimatedby densitometric analysis ofthe autoradiographs.
Immunoelectron Microscopy.
￿
Afterstimulation ofcellswith anti-
CD3e mAb, cells were fixed with 3% parafonnaldehyde and 0.1
glutaraldehyde in 0.1 M phosphate buffer, pH 7.3, for 30 min at
room temperature. They were infused with a graded series of su-
crose solution up to 2.3 M in 0.1 M PBS and were then quickly
frozen with liquid Freon 22. Ultrathin sections were cut with a
cryo-ultramicrotome (Ultracut Om-U4 equipped with FC-4;
Leica, Wetzler, Germany) . Ultrathin frozen sections were col-
lected on Formvar-coated grids and were double-stained with
anti-TCR-(3 and CD3e mAbs by using the following procedure
(30). Sections were washed with 50 mM glycine in PBS, blocked
with 2% gelatin, 2% BSA in PBS, and then stained with 10 lt,g/
ml ofanti-CD3e (145-2C11), followed by colloidal gold-labeled
protein A (AmershamCorp., Arlington Heights, IL). Afterwash-
ing, the sections were blocked with X10-diluted normal mouse
serum and incubated with 10 N.g/ml of biotin-labeled anti-
TCR-(3 (H57-597) mAb followed by colloidal gold-labeled
streptavidin (Amersham Corp.) . After further washing, they were
fixed with 2.5%glutaraldehyde in 0.1 M sodium cacodylate buffer,
stained with 0.3% uranyl acetate oxalate, and transferred to the
surface of a uranyl acetate-methylcellulose mixture. After stand-
ing for 10 min, the sections were embedded in the same mixture
and examined under an electron microscope (model JEM 1200
EX; JEOL, Tokyo, Japan) .
Results
Differential Modulation of TCR by mAbs to the TCR-CD3
Complex. In a previous study, we reported that an allo-
anti-IJ mAb inhibited signal transduction induced by anti-
TCR but not by anti-CD3 (16). Transfection of various
TCR-~ chain constructs into T cell hybridomas that lack
TCR-t chains indicated the presence oftwo parallel signal-
transducing units in the TCR-CD3 complex (4, 5) . The
results of these studies suggest that the TCR undergoes dis-sociation from CD3 when the TCR complex is ligated.
Thus, we undertook this study to define the molecular
mechanism of the dissociation of the TCR-CD3 complex .
Whole C3H spleen cell suspensions were incubated with
either anti-TCR or anti-CD3 mAb or medium for 0, 3,
15, and 45 min at 37°C . The samples were harvested and
washed, and the cells were subjected to immunofluores-
cence staining with anti-TCR or anti-CD3 mAbs . In the
cultures treated with medium as a control or with anti-
TCR mAb, there were no significant changes in the level
of cell surface expression of either TCR or CD3 over the
45-min time course ofthe experiment (Fig . 1) . In contrast,
after 15 min ofincubation in the presence of anti-CD3, the
level of surface TCR-(3 expression was reduced (down-
modulated) >50%, whereas the level of CD3 expression
was not affected . Even after 45 min of incubation with
anti-CD3, cell surface expression ofCD3 remained at con-
trol levels, although the TCR surface expression had been
down-modulated by 90% . Treatment with ionomycin did
not induce the down-modulation of the TCR-CD3 com-
plex . Treatment with anti-CD2 mAb also did not affect the
cell surface expression of the TCR-CD3 complex (data
not shown) . These results suggested that, after treatment
with anti-CD3 mAb, the TCR-R is uncoupled from CD3
and is selectively down-modulated .
Immunoelectron Microscopy of Ultrathin Frozen Sections Dou-
bly Stained with Anti-TCR and Anti-CD3 .
￿
We wished to
Figure 1 . Cell surface expression of TCR and CD3 after stimulation
with anti-TCR-13, anti-CD3e mAbs, or ionomycin. Spleen cells were
stimulated with anti-TCR-l3 (H57-597), anti-CD3e (145-2C11) mAbs,
or ionomycin for 3, 15, and 45 min . After stimulation of the cells, two-
color staining was performed, and Thyl+ cells were analyzed usingFCM .
Each panel contains expression of TCR-(3 or CD3e of Thyl+ cells at
times 0, 3, 15, and 45 min after stimulation and is compared with that of
the Thyl - fraction at time 0 min as a negative control. Down-modula-
tion ofTCR was only observed when cells were stimulated with anti-
CD3 mAb .
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determine whether the down-modulation ofTCR mole-
cules that was observed after stimulation of the T cells with
the anti-CD3 mAb was due to the capping and subsequent
shedding with mAb or to the internalization ofTCR mol-
ecules . For this purpose, double-immunolabeled ultrathin
sections were analyzed by electron microscopy . Cells were
fixed with 3% paraformaldehyde and 0.1% glutaraldehyde
30 min after treatment with medium, anti-TCR, or anti-
C133 mAbs. Quick-frozen Ultrathin frozen sections were
stained sequentially with biotin-anti-CD3 and anti-TCR
mAbs, and each was followed by colloidal gold-labeled
protein A or streptavidin .
Fig. 2 shows immunoelectron micrographs of spleen
cells before and after treatment with medium (Fig . 2, a and
d), anti-TCR (Fig . 2 b) or anti-CD3 mAbs (Fig . 2, c and e) .
The labeling ofTCR (by 10 nm ofgold particles) and CD3
(by 15 nm ofgold particles) appeared uniformly on the sur-
face of cells incubated with medium (Fig . 2, a and d) .
There was no significant change in cell surface expression
of TCR or CD3 after treatment of the spleen cells with
anti-TCR mAb (Fig. 2 b) . These results are consistent with
the observations above, obtained by FCM analysis, which
indicate that no significant changes in the levels of surface
TCR or CD3 expression were seen . In the case ofthe anti-
CD3-treated cells, the labeling of the TCR was found to
be localized to the cytoplasm ofthe cells, whereas the label-
ing of CD3 was seen at the cell surface (Fig. 2, c and e) .
These results indicated that, after stimulation of T cells
with anti-CD3 rnAb, the TCR dissociated from the TCR-
CD3 complex and was down-modulated by internaliza-
tion . In contrast, the CD3 molecules remained at the cell
surface . Whether the TCR also dissociated from the
TCR-CD3 complex after treatment with anti-TCR mAb
could not be established from these results .
Dissociation of the TCR-a!/3 with ~ Chainfrom the TCR-
CD3 Complex after Stimulation . To investigate further the
effects ofanti-TCR and anti-CD3 treatment on the disso-
ciation ofthe TCR-CD3 complex, we attempted to quan-
tify the total amount ofTCR protein before and after in-
cubation of T cells with anti-TCR, anti-CD3 mAbs, or
medium by using immunoblot analysis . Spleen cells were
treated with the various agents for 30 min and then were
harvested and lysed with 1% NP-40 . Whole-cell lysates
were subjected to SDS-PAGE, and immunoblot analysis
was performed with an anti-TCR-a mAb. The total amounts
of TCR-a protein measured at different cell concentra-
tions from the three different treatments were essentially
similar (Fig . 3 a) . This result supports the notion that, after
treatment oftheT cells with anti-CD3, TCR dissociates from
the receptor complex and appears to be internalized such
that the overall amount ofTCR protein does not differ from
the cells treated with medium or anti-TCR, a condition in
which the TCR is not down-modulated .
We were curious whether the TCR-CD3 complex also
underwent a dissociatioe event when T cells were treated
with anti-TCR-R, even though the TCR did not appear
to undergo the down-modulation seen with the anti-CD3
treatment . Spleen cells were treated with anti-TCR or anti-Figure 2 . Immunoelectron micrographs ofspleen cells labeled with anti-TCR and anti-CD3 mAbs . (a and d) Spleen cells were cultured for 30 min with
medium, (b) stimulated with anti-TCR-13 mAb (H57-597), or (c and e) stimulated with anti-CD3e mAb (500.A2) . Colloidal gold-labeled streptavidin ;
10 or 15 run for biotin-anti-CD3e mAb, and 5 or 10 nm colloidal gold-labeled proteinA for anti-TCR mAb were used. In a-c, X33,000 ; bar, 500 nm ;
in d and e, X 132,000 ; bar, 200 run . Arrowheads (e) indicate cytoplasmic location ofTCR-(3 chain .
CD3 mAbs for 3 and 30 min . Cells were harvested and
lysed with 1% digitonin . The lysates were then subjected to
immunoprecipitation with either anti-CD3 (HMT3-1) (Fig.
3, b and c), anti-TCR-~ (H146-968) (Fig . 3 d), or anti-
TCR-R (H57-597) (Fig . 3 e) mAbs. The immunoprecipi-
tates were subjected to SDS-PAGE and subsequent immu-
noblot analysis with the anti-TCR-cx and anti-TCR-4 mAbs
(Fig . 3, b and d), antiphosphotyrosine (4G10) mAb (Fig . 3
c), or anti-TCR-(x and anti-CD3e mAbs (Fig. 3 e) as probes.
As shown in Fig . 3 b, the anti-CD3 immunoprecipitates
from both anti-TCR- and anti-CD3-treated spleen cells
after 30 min contain much less TCR (two- to threefold)
than that of the control (treatment with medium for 30
min) . The amount of TCR-~ chains coprecipitated with
anti-CD3e mAb was also decreased in a ratio similar to that
ofTCR obtained from both treatments . These results indi-
cated that a substantial amount ofTCR-ot chain was disso-
ciated from CD3e when T cells were stimulated with ei-
ther anti-TCR or anti-CD3 . Given that the cell surface
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expression of both TCR and CD3 was not affected by
treatment with anti-TCR mAb, these results indicate that,
as seen with the anti-CD3 treatment, dissociation of the
TCR and CD3 results from the treatment of the cells with
anti-TCR. However, the latter situation is not accompa-
nied with the down-modulation ofthe TCR .
An antiphosphotyrosine blot of anti-CD3 immunopre-
cipitates from the spleen cells treated with anti-TCR or
anti-CD3 mAbs is shown in Fig . 3 c. The amount of phos-
phorylated C chains precipitated with anti-CD3e from both
anti-TCR and anti-CD3 treatment after 30 min was in-
creased much more (two- to fourfold) than that from the
control . A 70-kD phosphorylated protein appeared after 3
min of treatment with anti-TCR, and anti-CD3, and re-
mained after 30 min of treatment with anti-TCR, but it
was not detected from the cell treated with anti-CD3 after
30 min . These results suggested that the signal transduction
events induced by anti-CD3 may differ from those induced
by anti-TCR .The anti-TCR-~ immunoprecipitates were analyzed by
immunoblot with the anti-TCR-ot and anti-TCR-C mAbs
as probes (Fig. 3 d) to study the association between TCR
and C chain during treatment with either anti-TCR or
anti-CD3 . The amount ofTCR-oc coimmunoprecipitated
with the TCR-~ chain was essentially similar to that from
cells treated with anti-TCR or anti-CD3 for 30 min .
These results suggested that TCR and C remain tightly as-
sociated and that these two components dissociate together
from the antigen receptor complex upon ligation by either
anti-TCR or anti-CD3 .
To confirm dissociation between TCR and CD3 after
stimulation of cells with anti-TCR or anti-CD3, analysis of
the anti-TCR-P immunoprecipitates was performed by
immunoblot, with anti-TCR-u and anti-CD3e as probes
(Fig. 3 e) . In this case, it was found that the amount of
CD3e coimmunoprecipitated by anti-TCR-P decreased
after treatment with either anti-TCR or anti-CD3 . The
total amount of TCR-ct protein immunoprecipitated was
not affected by the mAb treatments, however . This result
would be anticipated if the TCR dissociates from CD3
upon ligation of the TCR-CD3 complex by either anti-
TCR or anti-CD3 .
In summary, the results of these immunoprecipitation
experiments indicate that ligation of the TCR-CD3 com-
plex with r Ab is accompanied by the dissociation of the
complex in such a manner that the TCR and C chains sep-
arate from the CD3e . In addition, a differential conse-
quence results from anti-CD3 ligation as compared with
anti-TCR ligation : The former situation leads to down-
modulation of the TCR, whereas the latter does not .
Effect of TCR Ligation with Superantigen or an anti-V08
mAb . We wish to determine whether the dissociation of
the TCR and CD3 mediated by ligation ofthe TCR-CD3
complex by anti-TCR could also be demonstrated when
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Figure 3 . Immunoblotting analysis of TCR-a, CD3e, and TCR-t chains
after stimulation with anti-TCR-P or anti-CD3e mAbs for 30 min . (a) The
amount of TCR-a chain from whole-cell lysates of spleen cells . (b) The
amount ofTCR-ct and -C chains from the immunoprecipitates of spleen cells
with anti-CD3e mAb ; densitometric units are for the signal ofTCR-a chain .
(c) The phosphotyrosine blot of the immunoprecipitates with anti-CD3e
mAb . An arrow indicates phospho-~ chain; densitometric units are for the
signal ofphospho-C chain . (d) The amount ofTCR-o . and -C chains from the
immunoprecipitates with anti-TCR-C mAb; densitometric units are for the
signal of TCR-ot chain . (e) The amount ofTCR-a and CD3e chains from
the immunoprecipitates with anti-TCR-P mAb . Molecular mass markers are
indicated at the left side ofthe figure in kilodaltons (b-d) .
the TCR-CD3 complex is ligated with anti-VP mAb or a
superantigen . For this purpose, spleen cells from transgenic
mice bearing a TCR VR8 specific for the HY antigen were
stimulated with either an anti-VR8 mAb or a superantigen,
SEB (17) . Murine TCR VR8 is known to be reactive to
SEB . Immunofluorescence staining analysis with anti-
TCR-P or anti-CD3e mAbs was performed after the stim-
ulation of spleen cells . As shown in Fig. 4 a, no down-
modulation of the TCR-CD3 complex was observed even
after 45 min of incubation with either anti-VR8 mAb or
SEB . This result is consistent with the lack ofTCR down-
modulation that was seen in the spleen cells treated with
anti-TCR mAb, as described in Fig. 1 .
Evidence for the dissociation was obtained from the
analysis of immunoprecipitates with the anti-CD3 mAb of
lysates of cells treated with either anti-VR8 mAb or SEB .
The results of immunoblot analysis of these immunopre-
cipitates, using the anti-TCR-ot mAb as the probe, showed
that the amount ofTCR coimmunoprecipitated with anti-
CD3e was reduced similarly, either with the anti-VR8 or
SEB . These results indicate that the dissociation of the
TCR from the TCR-CD3 complex is also induced when
the receptor complex is ligated by SEB as well as another
anti-TCR reagent, anti-VR8 mAb . Thus, it appears that
the dissociation of the TCR-CD3 complex is a general re-
sponse to ligation of the TCR-CD3 complex either by
anti-TCR mAb or superantigen .
TCR-CD3 Dissociation in T Cell Clones . Finally, we
sought to determine whether the anti-TCR- or anti-
CD3-induced uncoupling ofTCR and CD3 would occur
in T cell clones, which were maintained in vitro for > 1 yr
by antigen stimulation and IL-2 supplementation . Two T
cell clones, MS-S2 (I-Ak autoreactive) and 24-2 (specific
for KLH in the context of I-Ab), were stimulated with anti-
TCR or anti-CD3 mAbs for 0, 3, 15, and 45 min in theFigure 4 . Uncoupling between TCR and CD3 complex after stimula-
tion of spleen cells from V(38 transgenic mice with anti-V(38 mAb or
SEB . (a) Cell surface expression of TCR-13 and CD3e after stimulation
with anti-V(38 mAb (F23 .1) or SEB . Spleen cells from V(38 transgenic
mice were stimulated with anti-V138 mAb (F23 .1) or SEB for 3, 15, and
45 min. After stimulation, cells were stained with anti-TCR-(3 and anti-
CD3e mAbs and analyzed by FCM. (b) Inununoblot analysis of TCR-a
proteins from the immunoprecipitates with the anti-CD3e mAb after
stimulation of spleen cells from V(38 transgenic mice with anti-V(38 mAb
or SEB for different times, as indicated in the figure . Densitometric units
indicate the signal of TCR-cr chain .
presence of the B cell hybridoma, LK35.2, which is a Fcy
receptor-positive cell line . In both T cell clones, no down-
modulation of TCR-(3 or CD3e expression was observed
upon stimulation with anti-TCR over the time course of
the experiment (Fig. 5) . Thus, like normal resting cells, li-
gation of the TCR-CD3 complex by anti-TCR does not
result in the down-modulation of the surface-expressed
TCR . In the case of the treatment with anti-CD3, how-
ever, cell surface expression of TCR was rapidly down-
modulated in both T cell clones (Fig . 5) . In fact, within 3
stimulated with
anti-TCRS
anti-CD3e
a
MS-S2 (I-Ak)
TCRO CD3e
24-2 (I-Ab+KLH)
TCRO CD3e
Loglo fluorescence
￿
Loglo fluorescence
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min the down-modulation of the TCR reached maximal
level . Furthermore, some down-modulation of the CD3
complex was detected after 45 min of treatment with anti-
CD3, and by 45 min as much as 30% reduction in the CD3
level was measured . Thus, T cell clones also showed mod-
ulation ofTCR from the cell surface upon stimulation
with anti-CD3 . The dissociation response o£ T cell clones
upon ligation of the TCR-CD3 complex appeared to be
more rapid than that of resting spleen cells .
Discussion
Previous studies demonstrate that there is functional un-
coupling between TCR and CD3 complexes in either im-
mature or mature T cells after ligation of the TCR-CD3
complex (12-16) . In the case of immature CD4+ 8+ thy-
mocytes, cells that are resistant to anti-TCR mAb injection
are unable to mobilize intracellular Cal' upon further stim-
ulation with the anti-TCR mAb . However, these cells are
eliminated when mice are treated with anti-CD3 mAb
(12) . This result led us to hypothesize that there is a physi-
cal dissociation of the TCR-CD3 complex upon receptor
ligation .
In this study, we demonstrate two major observations .
First, from the analysis of cell surface expression ofTCR-R
or CD3e before and after stimulation, as detected by flow
cytometry (Fig . 1), anti-CD3 treatment of the T cells re-
sulted in the down-modulation of the TCR-a/(3, whereas
surface expression level of CD3e was not affected . In con-
trast, anti-TCR treatment failed to modulate the surface
expression of either TCR-a/(3 or CD3e . As shown by im-
munoelectron micrography (Fig . 2), this specific down-
modulation of the TCR-a/(3 by anti-CD3e treatment ap-
peared to be due to internalization . Second, the amount of
TCR-a/(3 coimmunoprecipitated with ~ chain was not
changed by treatment with either anti-CD3 or anti-TCR ;
however, the amount of TCR-ot/(3 coimmunoprecipitated
with anti-CD3e significantly decreased after 30 min of
treatment with anti-TCR and anti-CD3 (Fig . 3) . From an
analysis of a shorter exposure of the immunoblot in Fig . 3
b, the amount of~ chains precipitated with anti-CD3e was
decreased in a ratio similar to that of TCR-cx/(3 obtained
Figure 5 . FCM analysis of TCR-(3 and CD3e chain of
T cell clones after stimulation . (a) I-A' autoreactive T
cell clone, MS-S2 . (b) I-Ab-restricted KLH-specific T
cell clone, 24-2. T cell clones mixed with LK35 .2, a B
cell hybridoma, were stimulated with anti-TCR-(3 or
anti-CD3e mAbs for 3, 15, and 45 min . At each time
point, cells were harvested and stained with anti-Thyl
and anti-TCR-(3 or anti-CD3e mAbs . Thyl+ cells were
analyzed .from both treatments. These results suggested that the
TCR dissociation from CD3 complex occurred in such a
manner that the TCR-ot/p and associated ~ chains are re-
leased as a unit.
In Fig. 6, we present a view of the physical dissociation
of TCR and CD3 that results after treatment with anti-
TCR or anti-CD3 mAbs. Both anti-TCR and anti-CD3
mAb's ligation of the TCR-CD3 complex mediates disso-
ciation of the complex in such a way that TCR and ~
chains remain associated. In the case of anti-CD3e stimu-
lation, the dissociated TCR is down-modulated by inter-
nalization, whereas the CD3 complex remains at the cell
surface. TCR-CD3 ligation through the TCR by anti-
TCR-[3, anti-VP8, or superantigen (SEB) does not affect
the surface expression of either TCR or CD3, whereas the
TCR-CD3 complex undergoes dissociation.
Although we have not presented all of our data, two dif-
ferent anti-CD3 mAbs (145-2C11 and 500.A2) and five
different anti-TCR reagents (H57-597; anti-TCR-[3 con-
stant region, F23.1 ; anti-TCR V[38, A2134; anti-TCR-ot
of 2B4TCRotp Tg mice, 1132; anti-TCR-ot of 2C Tg
mice, T3.70; and anti-TCR-o of HY Tg mice) were
tested, and results basically similar to those shown in Fig. 1
were obtained with all of the reagents. The TCR-CD3
dissociation upon stimulation ofTCR V[38 Tg T cells with
SEB was investigated (Fig. 4), and evidence for the dissoci-
ation of TCR from CD3 was obtained; however, no
down-modulation of TCR was observed. In addition,
TCR appeared to be dissociated from CD3 in the stimula-
tion with specific peptides and MHC in the 2C Tg system
(data not shown) .
Several groups have reported the co-down-modulation
of TCR-ot/p and CD3y8e when the TCR-CD3 complex
was stimulated with multivalent cross-linking of anti-TCR
mAb or anti-CD3 mAb with anti-mouse antibodies (31,
anti-TCRO stimulation anti-CD3e stimulation
Figure 6. Dissociation and down-modulation of TCR-ot/p accompa-
nied with TCR-C from the CD3 complex. This model illustrates the dis-
sociation ofTCR-ot/(3 and CD3 components that accompanies the liga-
tion of the TCR-CD3 complex by anti-TCR and anti-CD3 mAbs. Both
anti-TCR and anti-CD3 mAb's ligation ofthe TCR-CD3 complex me-
diates dissociation ofthe complex in such a way that TCR and C chains
remain associated. Anti-CD3e stimulation causes dissociation ofTCR-ct/(3,
and the dissociated TCR is down-regulated by internalization with TCR-~
chain, whereas CD3 components still express at the cell surface. TCR-CD3
ligation through the TCR by anti-TCR-(3, anti-V(38, or superantigen (SEB)
does not affect the surface expression ofeither TCR-ot/p or CD3.
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32). In these reports, TCR-a/[3 was down-modulated co-
incident with CD3y8e. Two major differences in the ex-
perimental system might serve to explain the differences
between their experiments and ours. First, we stimulated
TCR or CD3 molecules by using cell-cell interactions.
When anti-TCR or anti-CD3 mAbs were added to the
spleen single-cell suspensions, splenic FcR+ cells played the
role of a cross-linker, because anti-FcR mAb (2.4G2) abro-
gated the effect of these antibodies. In physiological condi-
tions, the TCR ligation with antigenic peptide on MHC
molecules must be mediated by direct cell-cell interactions.
During the interactions of T cells and APC, so-called core-
ceptor molecules, including various adhesion molecules,
are expected to be stimulated. In our system, sufficient
coreceptor signals should be operative in the stimulation
using antibodies. In addition, the observations obtained as a
result of stimulation with SEB and MHC molecules were
similar to those obtained by stimulation with anti-TCR
mAbs in our system. Second, we analyzed only very early
(up to 1 h) molecular events afterTCR ligation. Intracellu-
lar signal transduction events induced directly by TCR li-
gation should be examined within a few minutes to 1 h.
For instance, tyrosine kinases are known to be activated
within 1 min after TCR ligation, and their activities de-
crease quickly and return to baseline levels after 1 h (33).
Changes in the intracellular signaling molecules after sev-
eral hours might be the result of multiple cellular events,
including the activation and inactivation of various genes
(34) . In fact, in our system, cell surface expression of CD3e
was substantially decreased after overnight stimulation with
either anti-TCR or anti-CD3 mAbs.
In the immature T cell, signal transduction via the CD3
complex plays an important role in the differentiation of
the CD4 - 8- (double-negative [DN]) thymocytes to the
CD4+8+ (double-positive) stage (35, 36). Thymocytes in
RAG-1' or RAG-2-1- mice are stacked at the DN stage
because of the lack of TCR-[3 rearrangements (37-40) . In-
jection of anti-CD3 mAb into RAG-2-/- mice or treat-
ment of fetal thymus organ cultures of RAG-1 -/- mice
with anti-CD3 not only induced differentiation of DN
thymocytes to double-positive thymocytes but also resulted
in a dramatic increase in the cell numbers in the thymus
(35, 36). These studies suggest that signal transduction via
the CD3 complex may compensate for the requirement of
TCR-[3 gene rearrangement in DN thymocytes and may
differ from the signal transduction via the TCR-ot/[3. In
our studies, we found a qualitative difference in the re-
sponses to the two treatments (anti-TCR versus anti-CD3)
in that neither anti-TCR mAbs nor SEB treatment resulted
in down-modulation ofTCR-CD3. These results indicate
that early events in T cell activation, such as Caz+ influx or
activation of tyrosine kinases itself, may not play an impor-
tant role in the process of TCR down-modulation. Al-
though TCR-a/[3 linked to the TCR-~ chain dissociated
from the CD3 complex (Fig. 3 c), there is the possibility
that phosphorylation of tyrosine kinases or TCR-~ chain is
involved in the dissociation of the TCR and the CD3
complex.Julius and his colleagues observed that pretreatment with
anti-CD4 mAb inhibited anti-TCR mAb-mediated activa-
tion but failed to inhibit activation with anti-CD3 n Ab
(14) . They also observed, using T cell clones, that associa-
tion of the tyrosine kinase p56Ick with CD4 inhibited stim-
ulation with anti-TCR mAb but did not alter the effect of
anti-CD3 r Ab treatment (15) . In Fig. 3 c, the amount of
phosphorylated ~ chains induced by anti-CD3 treatment
was twofold greater than that induced by anti-TCR treat-
ment; also, a 70-kD phosphorylated protein (ZAP-70 or
Syk?) was still detected 30 min after treatment with anti-
TCR mAb, whereas the 70-kD phosphoprotein induced
by anti-CD3 treatment was already dephosphorylated or
dissociated from the TCR-CD3 complex under similar
conditions. These results could be interpreted as suggesting
that signal transduction events induced by anti-TCR n Ab
are distinguishable from those induced by anti-CD3 mAb.
These observations raise the possibility that tyrosine kinases
such as p56Ick and p59f'° play a key role distinguishing sig-
nal transduction through TCR-tx/(3 from that through the
CD3 complex. Different combinations of tyrosine kinases
may provide the dissociation, followed by down-modula-
tion of TCR, although natural ligation of TCR-CD3
complex resulted in dissociation on the cell surface without
down-modulation of TCR-oa/(3 (see Fig. 4).
TCR-CD3 complex is known to be a unit composed of
at least eight polypeptides, i.e., a(3y8ee~~ in normal T cells
(1-4) and immature thymocytes (11). Recently, reports
have demonstrated atypical TCR-CD3 complexes in tu-
mor-bearing mice (41, 42) . Spleen T cells in tumor-bear-
ing mice expressed low amounts of CD3y and undetect-
able TCR-~, but expressed the FCERI-y chain (41) . Aoe et
al. also reported the structural changes of CD3ybe and the
loss of TCR-4 in TCR complex on spleen T cells in tu-
mor-bearing mice (42). These atypical receptor complexes
References
were found to be poor in function as assessed by calcium
mobilization (41), which might account for the diminished
immune responses in tumor-bearing hosts.
We suspect, from the results presented here, that the dis-
sociation of the TCR and the CD3 complex could help
explain the unresponsiveness of T cells after stimulation
and may regulate the strength of signal transduction via the
TCR-CD3 complex, because we have observed in prelim-
inary studies that anergic T cells induced by stimulation
with Mls antigen did not show down-modulation of TCR
by anti-CD3 treatment (data not shown) . This observation
suggests that Mls stimulation results in dissociation of the
TCR-CD3 complex, so subsequent treatment with anti-
CD3 would not be expected to cause down-modulation of
the TCR.
Recent studies on TCR-altered peptide antagonists and
partial agonists have suggested that TCR peptide antago-
nists and partial agonists delivered an insufficient signal to T
cells . This caused partial phosphorylation ofTCR-~ chains,
resulting in the lack of association of ZAP-70 with the
TCR-CD3 complex (43, 44). When the T cell clone was
stimulated with APC plus TCR-altered peptide antagonists
or partial agonists, TCR-~ chains were never fully phos-
phorylated. However, with antigenic peptides, fully phos-
phorylated TCR-~ chains (21 kD) were detected. The par-
tially phosphorylated TCR-~ chains failed to associate with
ZAP-70. Thus, the antagonists or partial agonists induce an
insufficient signal that nevertheless could block the subsequent
signaling induced by the immunogenic ligand (sufficient
signal). The inhibitory effect of TCR peptide antagonists
on T cell stimulation could be explained mechanistically as
a result of the physical dissociation of TCR-CD3 com-
plexes. The relationship of the phenomena induced by al-
tered peptide ligation and the dissociation of TCR-CD3
complexes requires further examination.
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